Responses
Research Article
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
Compose a Response to This Article
Other responses
No responses have been published for this article.